REPLIMUNE GROUP, INC. Capitalized Computer Software, Amortization
REPLIMUNE GROUP, INC. (REPL) reported Capitalized Computer Software, Amortization of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareAmortization1 · last filed 2026-08-14
- REPLIMUNE GROUP, INC. capitalized computer software, amortization for the quarter ending 2026-06-30 was $300.00K, a 0.00% change year-over-year.
- REPLIMUNE GROUP, INC. capitalized computer software, amortization for the quarter ending 2025-12-31 was $300.00K, a 0.00% change year-over-year.
- REPLIMUNE GROUP, INC. capitalized computer software, amortization for the quarter ending 2025-09-30 was $300.00K.
- REPLIMUNE GROUP, INC. capitalized computer software, amortization for the quarter ending 2025-06-30 was $300.00K.
| Period end | Capitalized Computer Software, Amortization 3 month | Capitalized Computer Software, Amortization 3 month as first filed | Capitalized Computer Software, Amortization 6 month | Capitalized Computer Software, Amortization 6 month as first filed | Capitalized Computer Software, Amortization 9 month |
|---|---|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-14 | ||||
| 2025-12-31 | $300.00K 10-Q · filed 2026-02-03 | $600.00K derived: sum of 2 quarters · filed 2026-02-03 | $900.00K 10-Q · filed 2026-02-03 | ||
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-06 | $600.00K 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-14 | ||||
| 2024-12-31 | $300.00K 10-Q · filed 2026-02-03 | $300.00K derived: sum of 2 quarters · filed 2026-02-03 | $400.00K 10-Q · filed 2026-02-03 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $100.00K 10-Q · filed 2024-11-12 | $0.00 10-Q · filed 2025-11-06 | $100.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |